Paramesu Biotech IPO Details

MAINBOARD

Paramesu Biotech IPO DRHP (Draft Red Herring Prospectus) has been SEBI Approval Received.

The Lead Managers for Paramesu Biotech IPO are crucial for the offering's success. They are responsible for a wide range of tasks, including preparing the company for the public market, managing the regulatory filings, and marketing the IPO to potential investors. The lead manager for this offering is Pantomath Capital Advisors Pvt Ltd. To assess their past performance and success in previous IPOs, you can view the Lead Manager Performance Summary report.

For detailed information, Refer to the Paramesu Biotech Limited DRHP.

Paramesu Biotech IPO Details

Open Date

Close Date

Listing Date

Issue Price

₹0 - ₹0

Face Value

₹5 per share

Lot Size

GMP

₹0

Issue Type

IPO

Listing On

NSE, BSE

Type

Book Built Issue

Share holding pre issue

Share holding post issue

Total Issue Size

Fresh Issue

Offer for Sale

DRHP Status

SEBI Approval Received

Paramesu Biotech IPO Lot Size

Application	Lots	Shares	Amount
To be announced

Paramesu Biotech IPO Reservation

Promoter Holding

Pre Issue:92.19%

Post Issue:-

Promoter Names:

Company namely, Unimark Business Solutions Private Limited, Speedfast Tracom Limited, Ananada Swaroop Adavani, Mani Swetha Tetali, Himabindu Tetali

Documents

› Paramesu Biotech IPO DRHP

Paramesu Biotech IPO Valuations

ROE:23.30%

ROCE:18.13%

RONW:23.30%

Paramesu Biotech Financial Information

Period Ended	30 Sep 2024	31 Mar 2024	31 Mar 2023	31 Mar 2022
Assets	479.44	439.68	319.17	238.88
Total Income	409.39	629.29	625.34	496.6
Profit After Tax	26.85	40.34	32.52	33.97
Net Worth	200.1	173.12	132.96	100.95
Total Borrowing	216.18	205.88	140.56	81.98
Amount in ₹ Crore

About Paramesu Biotech IPO

Incorporate 2011, Paramesu Biotech Limited is a manufacturer of maize based speciality products in India, such as liquid glucose, corn oil, corn syrup, and maltodextrin.

The company offers a diversified portfolio of maize based speciality products, including native maize starch, modified maize starches, liquid glucose, maltodextrin powder, and co-products like germs, gluten, fiber, corn steep liquour and enriched fibre, amongst others.

The company currently operates out of its production unit in Andhra Pradesh's West Godavari District, Devarapalli.

Paramesu Biotech Limited's major customers include Emami Paper Mills Limited, Tunav Food Products LLP, Singhania Foods International, Prayagh Consumer Care Private Limited, S.A. Pharmachem Private Limited, ALMS Food Private Limited, Shree Vijay Oils, Shri Guru Oil Industries, Vikas Cattlefeed, PT Torabika Eka Semesta, Lotus Essential SDN BHD, and PT. Lamtana Multijaya.

Strength Of Paramesu Biotech IPO

To be announced

Risk Of Paramesu Biotech IPO

To be announced

Objectives Paramesu Biotech IPO

To be announced

Company Contact Details

Paramesu Biotech Ltd.
RS. No. 972,
3rd KM on Gopala Puram Road
West Godavari, Devarapalli – ,
Andhra Pradesh, 534313
Phone: 0883 2945700
Email: cs@paramesu.com
Website: http://www.paramesu.com/

Registrar Contact Details

Name: Bigshare Services Pvt Ltd

Phone: +91-22-62638200

Email: ipo@bigshareonline.com

Website: https://ipo.bigshareonline.com/ipo_status.html

Lead Mangers

Pantomath Capital Advisors Pvt Ltd
(Past IPO Performance)

Lead Manager Reports

IPO Lead Manager Performance Summary

Paramesu Biotech IPO - FAQs

The Paramesu Biotech IPO is a MAINBOARD public issue comprising 0 equity shares with a face value of ₹5 each, aggregating to a total issue size of . The issue price has been fixed at ₹0 per equity share, and the minimum application size is 0 shares.

The IPO opens for subscription on TBA, and closes on TBA.

Bigshare Services Pvt Ltd has been appointed as the registrar to the issue. The equity shares are proposed to be listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE).

The Paramesu Biotech IPO opens on TBA.

Paramesu Biotech IPO lot size is 0, and the minimum amount required for application is ₹0.

You may apply for the Paramesu Biotech IPO online by using either the UPI or ASBA payment method. The ASBA facility is available through the net banking platform of your respective bank. The UPI-based IPO application option is typically provided by brokers that do not offer banking services. For detailed guidance on the online IPO application process, please refer to the procedures outlined by Zerodha, Groww, Upstox, 5Paisa, Paytm Money, Fyers, Alice Blue, Nuvama, HDFC Bank, ICICI Direct, Kotak Securities, Axis Direct, and SBI Bank.

The Basis of Allotment for the Paramesu Biotech IPO is scheduled to be finalized on TBA. Subsequently, the shares allotted will be credited to investors’ demat accounts by TBA. Investors are advised to regularly check the Paramesu Biotech IPO allotment status for updates.

The listing date for the Paramesu Biotech IPO has not yet been officially announced. However, the tentative listing date is scheduled for TBA.

Paramesu Biotech IPO Grey Market Premium (GMP) refers to the unofficial price at which the company’s IPO shares are traded in the grey market prior to their listing on the stock exchange. The GMP serves as an indicator of investor demand, expected listing gains, and the overall market sentiment toward the IPO.

As of now, the current GMP stands at TBA.